Allergan delays drug that would rival Regeneron's Eylea

[riky]

Allergan delays drug that would rival Regeneron's Eylea

<p><a href="http://news.yahoo.com/allergan-delays-drug-rival-regenerons-eylea-185323020.html"><img src="http://l3.yimg.com/bt/api/res/1.2/VPfLxsnsrDtwDz6xRvegXA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-05-01T185323Z_1_CBRE9401GHK00_RTROPTP_2_HEALTH-SUMMIT.JPG" width="130" height="86" alt="Pyott, CEO of Allergan, speaks during the Reuters Health Summit in New York" align="left" title="Pyott, CEO of Allergan, speaks during the Reuters Health Summit in New York" border="0" /></a>By Esha Dey and Ransdell Pierson (Reuters) - Allergan Inc said approval of its Darpin eye drug could be delayed up to two years, providing a new boost to Regeneron Pharmaceuticals Inc whose successful treatment, Eylea, stands to gain from a lack of new competition. Shares of Allergan, which makes wrinkle treatment Botox, fell 13.1 percent after the company said mid-stage trial results of Darpin did not warrant an immediate move into far larger late-stage trials. Regeneron shares closed up 10.3 percent. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login